Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HUMAN IMMUNOGLOBULIN G for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 19 adverse event reports in the FDA FAERS database where HUMAN IMMUNOGLOBULIN G was used for Psoriasis.

Most Reported Side Effects for HUMAN IMMUNOGLOBULIN G

Side Effect Reports % Deaths Hosp.
Headache 7,885 11.2% 267 1,621
Off label use 5,872 8.3% 787 1,808
Fatigue 5,423 7.7% 314 1,361
Nausea 4,454 6.3% 256 1,266
Sinusitis 4,409 6.2% 92 1,008
Pyrexia 4,076 5.8% 275 1,583
Drug ineffective 3,923 5.6% 614 1,405
Pruritus 3,775 5.3% 223 434
Dyspnoea 3,518 5.0% 365 1,298
Malaise 3,180 4.5% 293 1,063
Pneumonia 3,150 4.5% 297 1,793
Urticaria 3,101 4.4% 14 335
Rash 3,065 4.3% 44 543
No adverse event 3,064 4.3% 81 419
Pain 3,026 4.3% 83 925

Other Indications for HUMAN IMMUNOGLOBULIN G

Immunodeficiency common variable (17,389) Product used for unknown indication (9,535) Primary immunodeficiency syndrome (6,769) Hypogammaglobulinaemia (5,295) Chronic inflammatory demyelinating polyradiculoneuropathy (4,735) Immunodeficiency (2,648) Secondary immunodeficiency (2,279) Myasthenia gravis (1,758) Selective igg subclass deficiency (1,386) Off label use (1,129)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

HUMAN IMMUNOGLOBULIN G Full Profile All Psoriasis Drugs HUMAN IMMUNOGLOBULIN G Demographics HUMAN IMMUNOGLOBULIN G Timeline